InvestorsHub Logo
Followers 23
Posts 2673
Boards Moderated 0
Alias Born 08/25/2010

Re: None

Monday, 07/13/2020 10:07:31 PM

Monday, July 13, 2020 10:07:31 PM

Post# of 232325
This is what we are up against, they will even go after other large BP

If they go head to head with other BP's. Do you really think they're going to allow us, a small time company to play in their sandbox? We're not going to be able to play until we have a BP partnership. NO WAY we get there alone, at least not anytime soon.


https://www.statnews.com/pharmalot/2020/07/13/gilead-viiv-hiv-glaxo-uk/

For the second time in less than two years, Gilead Sciences (GILD) has been reprimanded by a U.K. pharmaceutical industry trade group for disseminating information that unfairly compared one of its HIV drugs with a rival medicine sold by ViiV Healthcare. But this time, the drug maker was slammed for being a repeat offender and discrediting the entire industry.

The scolding occurs as Gilead braces for new competition from ViiV, a venture largely owned by GlaxoSmithKline (GSK). The companies have been battling over the lucrative HIV market for years, but ViiV is hoping to win regulatory approval next year for an injectable medicine for preventing the virus that leads to AIDS. And the looming showdown is being closely watched by Wall Street.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News